True affordability definitely helps with adoption I get what your saying and you're not wrong. My point is just the last piece of information is the most vital, a PLA was always going to happen esp off the back of the older test already having one. If the test is cheaper to produce reimbursement still needs to be high enough to make it commercially viable for labs to run and doctors to order. If the price is set too low the test might not be pushed because they can’t cover their costs, so even though it’s cheaper fewer people would actually get it. It's a weird delicate dance, economics must work which is the last piece we're waiting on. I'm bullish as always fundamentals haven't changed, but if the reimbursement comes back super favourable then the fire will be lit.
PIQ Price at posting:
37.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)